$207.13▾ 3.04%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 30% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Illumina, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days6 articles
5 bullish1 neutral0 bearish
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?